Yarrow Bioscience YARW Balance Sheet (2016-2026)

NASDAQ YARW
$29.11 -0.19 (-0.65%)
At close: Sep 9, 2026 · 4:00 PM EDT
Reported Financials

Yarrow Bioscience Quarterly Balance Sheet

Periods 38 quarters
Latest Jun 2026

Yarrow Bioscience reported total assets of $23.60M and total liabilities of $1.54M for the quarter ended Jun 2026, down 58.2% year over year. This balance sheet covers 38 quarters of results from Dec 2016 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
103.41M52.31M42.25M50.49M42.81M35.51M30.91M30.21M20.63M15.45M30.62M19.07M29.61M16.27M19.93M28.21M22.05M24.03M24.63M22.93M
Short-term InvestmentsInvestments (Current)
62.63M66.89M48.49M53.91M41.59M22.06M17.60M4.98M0.30M
Cash & Current Investments
103.41M52.31M42.25M50.49M42.81M35.51M30.91M30.21M20.63M15.45M93.25M85.95M78.10M70.19M61.52M50.27M39.65M29.01M24.93M22.93M
Receivables - NetNet Receivables
10.87M10.08M7.58M0.54M0.30M0.47M0.17M0.10M0.23M0.25M
Receivables - OtherOther Receivables
7.60M7.30M5.50M
Receivables
18.47M17.38M13.08M0.54M0.30M0.47M0.17M0.10M0.23M0.25M
Raw Materials
3.30M
Finished Goods
4.00M
Inventory
8.28M8.07M7.29M
Prepaid Assets
5.27M5.06M4.57M3.90M3.77M3.00M2.30M2.64M2.02M1.76M2.66M4.22M5.63M3.30M2.92M4.64M4.70M1.00M0.86M0.60M
Current Assets
128.43M76.13M63.19M60.65M51.92M44.05M38.27M33.02M22.96M17.51M95.96M90.22M83.78M73.53M64.44M54.91M44.34M30.01M25.79M23.53M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
0.50M0.47M0.35M0.31M0.30M0.13M0.11M0.11M0.10M0.09M0.08M0.08M
Long-Term Investments
Goodwill
Goodwill & Intangibles
Long-Term Deferred Tax
Other Non-Current Assets
3.83M3.68M7.84M3.35M2.97M2.73M2.48M2.24M2.00M1.76M1.51M1.27M2.72M2.54M2.26M1.34M0.24M0.06M
Non-Current Assets
5.56M5.19M3.86M3.67M3.27M2.86M2.48M2.24M2.00M1.76M1.72M1.45M2.87M2.66M2.47M1.51M0.38M0.15M0.08M0.08M
Assets
133.98M81.31M67.05M64.32M55.19M46.91M40.76M35.26M24.96M19.27M97.69M91.68M86.65M76.20M66.91M56.42M44.72M30.16M25.87M23.60M
Liabilities
Current Liabilities
Accounts Payables
10.08M7.62M6.51M3.61M1.43M2.52M2.39M2.21M1.16M0.72M1.66M2.79M4.52M3.99M2.71M3.53M1.41M1.04M0.26M0.61M
Notes Payables
Payables
10.08M7.62M6.51M3.61M1.43M2.52M2.39M2.21M1.16M0.72M1.66M2.79M4.52M3.99M2.71M3.53M1.41M1.04M0.26M0.61M
Accumulated Expenses
10.15M9.61M8.59M3.31M3.51M2.16M4.38M4.19M4.38M4.45M4.12M3.64M5.07M6.17M9.27M6.86M3.58M0.94M0.89M0.81M
Other Accumulated Expenses
0.10M0.10M1.31M1.31M1.31M1.31M
Short term Debt
33.38M
Current Leases
0.43M0.28M0.35M0.12M0.03M0.12M0.12M0.12M0.12M0.10M0.06M0.03M
Current Deferred Revenue
Total Current Liabilities
57.62M21.00M18.41M9.35M7.52M6.37M6.45M7.54M6.93M11.75M12.66M14.82M12.29M5.84M2.40M1.24M1.54M
Non-Current Liabilities
Non-Current Debt
Non-Current Deffered Revenue
Preferred Stock Liabilities
Minority Interest
0.21M
Operating Leases
1.25M1.05M0.35M0.21M0.06M0.03M0.10M
Other Non-Current Liabilities
0.45M0.45M1.31M1.31M1.31M1.31M1.31M
Total Non-Current Liabilities
58.64M21.98M7.52M6.37M6.45M1.41M1.38M0.03M
Total Liabilities
59.09M22.43M18.41M8.59M6.83M6.84M9.35M8.83M7.69M7.76M8.95M8.31M11.78M12.66M14.82M12.29M5.84M2.40M1.24M1.54M
Shareholder's Equity
Total Debt
33.38M
Common Equity
74.89M58.89M48.64M55.73M48.36M40.07M31.20M26.43M17.27M11.51M88.73M83.37M74.87M63.54M52.09M44.13M38.88M27.77M24.64M22.06M
Liabilities and Shareholders Equity
133.98M81.31M67.05M64.32M55.19M46.91M40.76M35.26M24.96M19.27M97.69M91.68M86.65M76.20M66.91M56.42M44.72M30.16M25.87M23.60M
Retained Earnings
681.56M686.84M688.16M690.58M691.68M692.85M693.94M694.94M695.84M696.65M780.04M781.02M781.92M782.65M783.24M783.91M784.42M785.42M785.87M786.31M
Treasury Shares
0.00M